Deborah Dunsire has been appointed president and CEO of H. Lundbeck AS, as of Sept. 1, 2018. Anders Götzsche, who has been acting as interim CEO and CFO since November 2017, will resume his position as CFO of the Danish neuroscience specialist. Most recently Dunsire was president and CEO of XTuit Pharmaceuticals Inc.. She was previously CEO of Forum Pharmaceuticals Inc. and Millennium Pharmaceuticals Ltd., both before and after it was acquired by Takeda Pharmaceutical Co. Ltd..
Astellas Pharma Inc. has promoted Yukio Mastui, hitherto head of EMEA operations, to the position of chief commercial officer
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?